Updated:
Healthy.Capital
Healthy.Capital is an Amsterdam-based venture firm deploying early-stage capital into European health-tech startups since 2020.
Healthy.Capital
Healthy.Capital launched in 2020 with a conviction that Europe's fragmented healthcare systems create asymmetric opportunity for technology-first founders. Based in Amsterdam, the firm targets pre-seed through Series A rounds, writing first checks that typically range from €500,000 to €2 million. The investment thesis rests on three pillars: digital health platforms that improve patient access, enterprise tools that streamline clinical workflows, and AI/ML applications trained on validated medical datasets. Portfolio construction favors concentrated positions — the firm holds fewer than 15 active names — allowing the principals to serve as hands-on board observers for each company. Deployment covers the Benelux region, DACH, and the Nordics, with selective exposure to the UK. The firm co-invests alongside generalist European seed funds and occasionally participates in pre-seed syndicates led by clinician-angels. Healthy.Capital does not operate a fund-of-funds sleeve or commit to blind-pool vehicles; every allocation results from a direct relationship with a founding team. The firm has backed companies operating in remote patient monitoring, AI-assisted radiology, and digital therapeutics. Public portfolio references remain limited — the firm discloses names selectively — but known co-investors within its network include early-stage managers with overlapping health-tech theses. The team size and total deployment figures remain undisclosed. Healthy.Capital has not published a formal AUM figure or announced successive fund closes, operating instead with a lean structure consistent with an emerging manager raising on a deal-by-deal basis or a single early fund vehicle. No additional offices outside Amsterdam have been confirmed. The firm maintains a low public profile, with no active LinkedIn page and no presence on major allocator databases. May 2024: The firm's website continued to display only its name, location, and sector focus — no track record, team, or portfolio details were added. What distinguishes Healthy.Capital structurally is its sector-exclusive mandate at the seed stage in a region where generalist funds still dominate health-tech deal flow. By refusing to dilute its clinical network and sourcing channels across fintech, climate, or enterprise SaaS, the firm operates more like a specialized family-office direct-investment book than a conventional venture capital partnership. This narrow aperture means its relevance to institutional allocators depends entirely on whether the underlying portfolio generates outlier returns in European digital health — a subsector historically starved of dedicated, non-crossover seed capital.
General information
Firm type
Private Equity
Year founded
2020
AUM
Undisclosed
Location
Region
Europe
Country
Netherlands
City
Amsterdam
Corporate office
Amsterdam, Netherlands
Sector focus
Frequently asked questions
What investment stages does Healthy.Capital target?
Healthy.Capital focuses on pre-seed, seed, and Series A rounds, typically writing first checks in the range of €500,000 to €2 million. The firm concentrates its capital in fewer than 15 active positions, allowing principals to take board observer roles. Later-stage follow-on participation is possible but not central to the stated strategy.
Which sectors does Healthy.Capital explicitly avoid?
The firm's mandate is exclusively concentrated on health-tech, and it deliberately avoids generalist allocations to fintech, enterprise SaaS outside clinical workflows, climate, and consumer internet. Within health-tech, the firm has not signaled interest in biopharma, medical devices requiring lengthy FDA or CE-mark regulatory pathways, or provider-side hospital operations.
How does Healthy.Capital source its deal flow?
The firm relies on a clinical network embedded in European academic medical centers and practitioner-led referrals, rather than cold inbound or aggregator platforms. By co-investing alongside clinician-angels and generalist seed funds with health-tech exposure, Healthy.Capital accesses pre-institutional rounds that require domain-specific due diligence. Its Amsterdam base gives proximity to the Benelux and DACH health ecosystems.
Is Healthy.Capital structured as a fund or does it invest deal by deal?
Healthy.Capital has not disclosed a formal fund structure or AUM. Its lean operational profile and low public visibility suggest either a single early fund vehicle or a deal-by-deal syndication model — both familiar patterns for European emerging managers. No regulatory filings confirming a closed-end fund structure are publicly available.
What geographic regions does Healthy.Capital cover?
The firm invests across the Benelux countries, DACH (Germany, Austria, Switzerland), and the Nordics, with selective exposure to the United Kingdom. Its Amsterdam headquarters situates it within one of Europe's densest health-tech corridors, though the firm has not disclosed portfolio company locations by country.
Does Healthy.Capital maintain any philanthropic or adjacent vehicle?
No philanthropic foundation, separate impact vehicle, or operating entity affiliated with Healthy.Capital has been identified in public records. The firm appears to operate as a single-purpose investment manager without adjacent family-office or foundation structures.
Who runs investment decisions at Healthy.Capital?
Healthy.Capital has not publicly disclosed its principals, investment committee members, or operating partners. No named individuals appear in available firm materials, regulatory registrations, or professional networking platforms as of mid-2024. The investment decision-making structure remains opaque to external allocators.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: